Martin O’Dea on Biomarkers, Longevity Innovation & the Future of Aging Science
Biomarkers are transforming longevity science, offering a way to validate interventions, track biological aging, and shape future healthcare policies. In this interview, Martin O’Dea discusses the latest advancements in biomarker science, the role of AI-driven diagnostics, and the path toward regulatory acceptance. Watch now to explore the future of aging research.
Biomarkers: The Key to Unlocking Healthy Longevity
Since measurable biomarkers are essential for tracking biological aging, assessing disease risk, and validating longevity interventions, they are shaping the future of healthcare. In this article, I explore the challenges of biomarker standardization, recent advances in proteomics, and how biomarker-driven regulation could transform aging research.
Michael Ringel on Gaps in Aging Science, Public Engagement, and Advancing Longevity
In this exclusive interview, Michael Ringel, MD at BCG, discusses two of Richard Barker’s '10 Wicked Issues in Healthy Longevity.' Discover key insights into the gaps in aging science, the importance of public engagement, and the economic opportunities tied to advancing healthspan. A must-watch for anyone invested in the future of longevity.
Bridging Gaps in Healthy Longevity: Insights from the JPMorgan Conference
The annual JPMorgan Health Conference provides a unique opportunity to gauge the state of life sciences and healthcare innovation. This year, key gaps in AI adoption and prevention-focused longevity therapies stood out, alongside promising discussions on advancing healthy aging. Discover insights from the event, the rise of GLP-1 therapies, and strategies to bridge critical gaps in longevity science.